Medical Devices Industry Reports Gel Stent Market | 页面 4

REPORT DESCRIPTION
Gel Stent Market - Competitive Landscape
Key players are focusing on research and development, in order to develop technologically advanced
products and enhance their product portfolio. The XEN (Allergan) received approval from the U.S. Food
and Drug Administration (FDA) in November 2016 and launched in the U.S. in early 2017. Major players
operating in the global gel stent market include Allergan, Alcon, Innfocus and Glaukos Corp.
On the basis of geography, the global gel stent market is segmented into North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in the
gel stent market, followed by Europe during the forecast period. The U.S. holds dominant position in the
market in this region due to continuous technological advancements and developed healthcare
infrastructure.
Get More Inf @ https://www.coherentmarketinsights.com/ongoing-insight/gel-stent-market-2404